Drug Trial Radar · NCT02045277
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Aug 20, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
212
Actual
Start
Feb 2014
Primary completion
Nov 2014
Study completion Nov 2014
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Dow Pharmaceutical Sciences
- First posted
- Jan 24, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to evaluate the safety and efficacy of a topical lotion
Conditions
- Plaque Psoriasis
Interventions
IDP-118 LotionDrug
Lotion
IDP-118 Monad HP LotionDrug
Active Comparator
IDP-118 Monad Taz LotionDrug
Active Comparator
IDP-118 Vehicle LotionDrug
Vehicle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Treatment Success of a 2-Grade IGA Score Improvement From Baseline and an IGA Score of Clear or Almost Clear at Week 8Time frame: 8 weeks
- Percentage of Participants With Treatment Success of a 2-Grade IGA Score Improvement From Baseline and an IGA Score of Clear or Almost Clear at Weeks 2, 4, 6, and 12Time frame: Weeks 2, 4, 6, and 12 (4-week follow-up)
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Valeant Site 13
Encino, California
Valeant Site 11
San Diego, California
Valeant Site 15
Santa Rosa, California
Valeant Site 10
Augusta, Georgia
Valeant Site 09
Newnan, Georgia
Valeant Site 08
Louisville, Kentucky
Valeant Site 04
Rockville, Maryland
Valeant Site 14
Clinton Township, Michigan
Valeant Site 07
Fridley, Minnesota
Valeant Site 01
East Windsor, New Jersey
Valeant Site 03
New York, New York
Valeant Site 17
Rochester, New York
Valeant Site 02
High Point, North Carolina
Valeant Site 05
Austin, Texas
Valeant Site 06
College Station, Texas
Valeant Site 16
Salt Lake City, Utah
Valeant Site 18
Lynchburg, Virginia
Valeant Site 12
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.